01—Abstract
Summary
Summary of the 8-K filed October 4, 2024. Cited figures are marked; the original filing is the authoritative source.
Twilio Inc. filed this Form 8-K on October 4, 2024 under Item 5.02 to report amendments to its executive severance arrangements.
On September 30, 2024, the Compensation and Talent Management Committee of the Board of Directors amended both the Amended Chief Executive Officer Severance Plan and the Senior Executive Severance Plan covering the non-CEO executive team. The amendments provide that a specified percentage of each participant's annual target bonus is payable upon a qualifying termination in connection with a change in control. Under the amended plans, a participant terminated without Cause, death or disability, or who resigns for Good Reason within the period beginning three months before and ending 12 months after a Change in Control becomes eligible for benefits.
These are subject to a general release of claims. The CEO plan provides a lump sum of 24 months of base salary plus 200%a of annual target bonus, up to 24 months of COBRA-equivalent employer health contributions, and full accelerated vesting of equity awards. The Senior Executive plan provides 18 months of base salary plus 150% of annual target bonus, up to 18 months of COBRA-equivalent contributions, and the same full equity acceleration.
Equity awards with performance conditions are deemed satisfied at target levels. The filing describes these as compensatory arrangements for certified officers and does not report any change in executive titles or board membership.
The full plan texts are filed as Exhibits 10.1 and 10.2, and the filing includes the Inline XBRL cover page as Exhibit 104. Investors may view the changes as relevant to potential executive retention and takeover-related costs, since the severance benefits are tied to a change in control.
02—Key points
Key Highlights
- Amended the CEO Severance Plan and Senior Executive Severance Plan on September 30, 2024 to add change-in-control severance terms.
- CEO benefit: lump sum of 24 months base salary plus 200% of annual target bonus, with up to 24 months of COBRA-equivalent health contributions.
- Senior Executive benefit: lump sum of 18 months base salary plus 150% of annual target bonus, with up to 18 months of COBRA-equivalent health contributions.
- Both plans provide full accelerated vesting of all outstanding and unvested equity awards upon a qualifying termination.
- Performance-conditioned equity awards are deemed satisfied at target levels under the amended plans.
- Qualifying termination window runs from three months before to 12 months after a Change in Control; benefits require a general release of claims.
- Full plan texts are filed as Exhibits 10.1 and 10.2 and incorporated by reference.
03—Questions
Frequently Asked Questions
What triggered this 8-K filing?
The filing reports under Item 5.02 that the Compensation and Talent Management Committee amended the CEO Severance Plan and the Senior Executive Severance Plan on September 30, 2024, to add change-in-control severance provisions.
Who is covered by the amended severance plans?
The CEO Severance Plan covers the Chief Executive Officer, and the Senior Executive Severance Plan covers the non-CEO members of the executive team.
When are severance benefits payable under the amended plans?
Benefits are payable if a participant is terminated without Cause, death or disability, or resigns for Good Reason within the period beginning three months before and ending 12 months after a Change in Control, subject to a general release of claims.
How do the benefits differ between the CEO and other senior executives?
The CEO receives 24 months of base salary and 200% of annual target bonus, with up to 24 months of COBRA-equivalent health payments. Other senior executives receive 18 months of base salary and 150% of annual target bonus, with up to 18 months of COBRA-equivalent health payments.
Where can investors find the full terms?
The complete amended CEO Severance Plan and Senior Executive Severance Plan are attached as Exhibits 10.1 and 10.2 to the filing and are incorporated by reference.
04—Continue